Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"breast cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Tarantino%2C+Paolo%22&type=Person&filter%5B%5D=topic_facet%3A%22breast+cancer%22
/vufind/Search/Results?lookfor=%22Tarantino%2C+Paolo%22&type=Person&filter%5B%5D=topic_facet%3A%22breast+cancer%22
Search /vufind/Search2/Results?lookfor=%22Tarantino%2C+Paolo%22&type=Person&filter%5B%5D=topic_facet%3A%22breast+cancer%22
PubPharm (11)
1
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer : the OXEL randomized phase II study
enthalten in:
medRxiv : the preprint server for health sciences
| 2023
von
Lynce, F.
|
Mainor, C.
|
Donahue, R.
| +26
UpdateIn: Nat Commun. 2024 Mar 27;15(1):2691. - PMID 38538574
Wird geladen...
2
Sequencing Antibody Drug Conjugates in Breast Cancer : Exploring Future Roles
enthalten in:
Current oncology (Toronto, Ont.)
| 2023
von
Fenton, M.
|
Tarantino, P.
|
Graff, S.
Wird geladen...
3
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer : Results from two international cohorts
enthalten in:
Cancer
| 2023
von
Weiss, A.
|
Martínez-Sáez, O.
|
Waks, A.
| +13
Wird geladen...
4
Filling the Gap after CDK4/6 Inhibitors : Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer
enthalten in:
Cancers
| 2023
von
Mittal, A.
|
Molto Valiente, C.
|
Tamimi, F.
| +4
Wird geladen...
5
The HER2-low revolution in breast oncology : steps forward and emerging challenges
enthalten in:
Therapeutic advances in medical oncology
| 2023
von
Nicolò, E.
|
Boscolo Bielo, L.
|
Curigliano, G.
| +1
Wird geladen...
6
Overcoming Resistance to HER2-Directed Therapies in Breast Cancer
enthalten in:
Cancers
| 2022
von
Schlam, I.
|
Tarantino, P.
|
Tolaney, S.
Wird geladen...
7
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy : early phase development
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Tarantino, P.
|
Antonarelli, G.
|
Ascione, L.
| +1
Wird geladen...
8
Understanding resistance to immune checkpoint inhibitors in advanced breast cancer
enthalten in:
Expert review of anticancer therapy
| 2022
von
Tarantino, P.
|
Barroso-Sousa, R.
|
Garrido-Castro, A.
| +5
Wird geladen...
9
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase development
enthalten in:
Expert opinion on investigational drugs
| 2022
von
Tarantino, P.
|
Antonarelli, G.
|
Ascione, L.
| +1
Wird geladen...
10
Margetuximab for the treatment of HER2-positive metastatic breast cancer
enthalten in:
Expert opinion on biological therapy
| 2021
von
Tarantino, P.
|
Morganti, S.
|
Uliano, J.
| +3
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: breast cancer
Medienart
11
Aufsätze
11
E-Artikel
11
E-Ressourcen
Zeitschriftentitel
2
Cancers
2
Expert opinion on biological therapy
2
Expert opinion on investigational drugs
1
Cancer
1
Current oncology (Toronto, Ont.)
1
Expert review of anticancer therapy
1
Therapeutic advances in medical oncology
1
medRxiv : the preprint server for health sciences
Alle anzeigen ...
weniger ...
Thema
breast cancer
9
Journal Article
6
Review
3
HER2-low
3
TNBC
2
Antibodies, Monoclonal
2
EC 2.7.10.1
2
Immune Checkpoint Inhibitors
2
Immunologic Factors
2
Immunotherapy
2
Receptor, ErbB-2
2
Research Support, Non-U.S. Gov't
2
clinical trials
2
immunotherapy
2
next-generation immune-checkpoint inhibitors
2
resistance
2
sacituzumab govitecan
2
sequencing
2
trastuzumab deruxtecan
2
triple negative breast cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2023
4
2022
1
2021
1
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
Haven't found what you're looking for?
Wird geladen...